KD Logo

Neurocrine Biosciences, Inc. [NBIX] Shares Fall -0.52 % on Thursday

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Neurocrine Biosciences, Inc. shares valued at $2,643,020 were sold by BENEVICH ERIC on Apr 15 ’24. At $133.36 per share, BENEVICH ERIC sold 19,818 shares. The insider’s holdings dropped to 40,778 shares worth approximately $5.4 million following the completion of this transaction.

Also, Delaet Ingrid sold 272 shares, netting a total of over 37,346 in proceeds. Following the sale of shares at $137.30 each, the insider now holds 7,507 shares.

Before that, Delaet Ingrid had sold 5,000 shares from its account. In a trade valued at $725,320, the Chief Regulatory Officer traded Neurocrine Biosciences, Inc. shares for $145.06 each. Upon closing the transaction, the insider’s holdings decreased to 5,000 shares, worth approximately $0.99 million.

Analysts at Deutsche Bank started covering the stock with ‘”a Buy”‘ outlook in a report released in mid December. Earlier on August 21, 2023, Mizuho resumed its rating. Their recommendation was “a Neutral” for NBIX stock.

Analyzing NBIX Stock Performance

During the last five days, there has been a drop of approximately -2.49%. Over the course of the year, Neurocrine Biosciences, Inc. shares have jumped approximately 0.59%. Shares of the company reached a 52-week high of $148.37 on 03/21/24 and a 52-week low of $128.00 on 02/07/24. A 50-day SMA is recorded $136.17, while a 200-day SMA reached $120.16. Nevertheless, trading volume fell to 0.58 million shares from 1.03 million shares the previous day.

Support And Resistance Levels for Neurocrine Biosciences, Inc. (NBIX)

According to the 24-hour chart, there is a support level at 130.96, which, if violated, would cause prices to drop to 129.38. In the upper region, resistance lies at 134.16. The next price resistance is at 135.78. RSI (Relative Strength Index) is 39.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.57, which suggests the price will decrease in the coming days. Percent R is at 85.67%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular

[the_ad id="945"]